The Ridgewood Blog Brings a Free Market Laissez-faire Point of View to Local, New Jersey State and National Issues.
the staff of the Ridgewood blog
Ridgewood NJ, in a groundbreaking development, the U.S. Food and Drug Administration (FDA) has approved the first-ever nasal spray to treat potentially severe allergic reactions. The new spray, marketed under the brand name Neffy, offers a needle-free alternative to traditional injectable epinephrine products like the EpiPen, which has been in use since 1987.
the staff of the Ridgewood blog
Ridgewood NJ, a novel nasal spray designed to prevent the neurodegeneration associated with dementia has shown promising results in mouse studies. The spray is a combination of two pre-existing drugs. Mice with neurodegenerative diseases showed improved cognition and less accumulation of toxic proteins in the brain after the spray was intranasally administered five times a week for a month. The combination of drugs was more effective at preventing neurodegeneration than each drug by itself. Human trials will start soon in several countries, including Japan and the US.
